<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="./10_1101_279570v3/results/search/country/results.xml">
  <result pre="to recover genomes from the 2018 Lassa fever outbreak in" exact="Nigeria" post="and to improve detection of viral infections in samples"/>
  <result pre="titer clinical samples from the 2018 Lassa fever outbreak in" exact="Nigeria" post="and to identify viruses in human and mosquito samples"/>
  <result pre="and cost-effective. Rescuing Lassa virus genomes in patient samples from" exact="Nigeria" post="To demonstrate the application of V ALL in the"/>
  <result pre="confirmed (by qRT-PCR) Lassa fever cases from Nigeria. In 2018," exact="Nigeria" post="experienced a sharp increase in cases of Lassa fever,"/>
  <result pre="LASV 45 , leading the World Health Organization and the" exact="Nigeria" post="Centre for Disease Control to declare it an outbreak"/>
  <result pre="Lassa fever outbreak. Points are colored by the state in" exact="Nigeria" post="that the sample is from (black is NTC). &amp;lt;;strong&amp;gt;;(b)&amp;lt;;/strong&amp;gt;;"/>
  <result pre="as in Fig. 4a and colored by the state in" exact="Nigeria" post="that the sample is from.&amp;lt;;/div&amp;gt;;&amp;lt;;/div&amp;gt;;&quot; data-icon-position=&quot;&quot; data-hide-link-title=&quot;0&quot;&amp;gt; Download figure"/>
  <result pre="Lassa fever outbreak. Points are colored by the state in" exact="Nigeria" post="that the sample is from (black is NTC). (b)"/>
  <result pre="as in Fig. 4a and colored by the state in" exact="Nigeria" post="that the sample is from. ;&amp;lt;;div xmlns=&quot;;http://www.w3.org/1999/xhtml&quot;;&amp;gt;;&amp;lt;;span class=&quot;;caption-title&quot;;&amp;gt;;Genomic applications"/>
  <result pre="ordered by amount assembled and colored by the state in" exact="Nigeria" post="that the sample is from. &amp;lt;;strong&amp;gt;;(b)&amp;lt;;/strong&amp;gt;; Viral species present"/>
  <result pre="in uncharacterized mosquito pools and pooled human plasma samples from" exact="Nigeria" post="and Sierra Leone after capture with V&amp;lt;;strong&amp;gt;;&amp;lt;;sub&amp;gt;;ALL&amp;lt;;/sub&amp;gt;;&amp;lt;;/strong&amp;gt;;. Asterisks on"/>
  <result pre="mosquito pools and pooled human plasma samples from Nigeria and" exact="Sierra Leone" post="after capture with V&amp;lt;;strong&amp;gt;;&amp;lt;;sub&amp;gt;;ALL&amp;lt;;/sub&amp;gt;;&amp;lt;;/strong&amp;gt;;. Asterisks on species indicate ones"/>
  <result pre="ordered by amount assembled and colored by the state in" exact="Nigeria" post="that the sample is from. (b) Viral species present"/>
  <result pre="in uncharacterized mosquito pools and pooled human plasma samples from" exact="Nigeria" post="and Sierra Leone after capture with V ALL ."/>
  <result pre="mosquito pools and pooled human plasma samples from Nigeria and" exact="Sierra Leone" post="after capture with V ALL . Asterisks on species"/>
  <result pre="of 25 individuals with suspected LASV or EBOV infections from" exact="Sierra Leone," post="as well as 5 pools of human plasma from"/>
  <result pre="of 25 individuals with acute fevers of unknown cause from" exact="Nigeria" post="and 5 pools of Culex tarsalis and Culex pipiens"/>
  <result pre="pools of Culex tarsalis and Culex pipiens mosquitoes from the" exact="United States" post="(see Methods for details). Using V ALL we detected"/>
  <result pre="one or more pools: 2 species in the pools from" exact="Sierra Leone," post="2 species in the pools from Nigeria, and 4"/>
  <result pre="more closely at the identified viral species, all pools from" exact="Sierra Leone" post="contained LASV or EBOV, as expected ( Fig. 4b)."/>
  <result pre="as expected ( Fig. 4b). The 5 plasma pools from" exact="Nigeria" post="showed little evidence for pathogenic viral infections; however, one"/>
  <result pre="to co-circulate with WNV and co-infect Culex mosquitoes in the" exact="United States" post="51 . These findings demonstrate the utility of capture"/>
  <result pre="O.A.F., A.Gob., D.G., and C.H. collected human plasma samples from" exact="Nigeria" post="and Sierra Leone. H.C.M. and K.J.S. formulated and performed"/>
  <result pre="D.G., and C.H. collected human plasma samples from Nigeria and" exact="Sierra Leone." post="H.C.M. and K.J.S. formulated and performed data analyses with"/>
  <result pre="Health (Jamaica Plain, Massachusetts), Irrua Specialist Teaching Hospital (Irrua, Nigeria)," exact="Nigeria" post="Federal Ministry of Health (Abuja, Nigeria), Sierra Leone Ministry"/>
  <result pre="Hospital (Irrua, Nigeria), Nigeria Federal Ministry of Health (Abuja, Nigeria)," exact="Sierra Leone" post="Ministry of Health and Sanitation (Free-town, Sierra Leone), Nicaraguan"/>
  <result pre="la Salud (Santo Domingo, Dominican Republic), Universidad Nacional Autónoma de" exact="Honduras" post="(Tegucigalpa, Honduras), Oswaldo Cruz Foundation (Rio de Janeiro, Brazil),"/>
  <result pre="microbial content was uncharacterized — 26 mosquito pools from the" exact="United States," post="human plasma from 25 individuals with acute non-Lassa virus"/>
  <result pre="25 individuals with suspected Lassa and Ebola virus infections from" exact="Sierra Leone" post="— we created sample pools by combining equal volumes"/>
  <result pre="the LASV genomes from the 2018 Lassa fever outbreak in" exact="Nigeria" post="and the EBOV genomes from the dilution series. For"/>
  <result pre="For our uncharacterized mosquito pools and human plasma samples from" exact="Nigeria" post="and Sierra Leone, after capture with V ALL we"/>
  <result pre="uncharacterized mosquito pools and human plasma samples from Nigeria and" exact="Sierra Leone," post="after capture with V ALL we searched for viral"/>
  <result pre="Organization. Lassa fever. http://www.who.int/emergencies/diseases/lassa-fever/en/&quot;diseases/lassa-fever/en/ ( 2018). Accessed: 2018-08-21. [47]. ↵" exact="Nigeria" post="Centre for Disease Control. An update of lassa fever"/>
 </snippets>
</snippetsTree>
